Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic Gram-positive bone and joint infections

Clinical Microbiology and Infection

Volumn 3, Issue 4, 1997, Pages 440-446

  Bernard, E ^a   Perbost, I ^a   Carles, M ^a   Michiels, A ^a   Carsenti Etesse, H ^a   Chichmanian, R M ^b   Dunais, B ^a   Dellamonica, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b PASTEUR HOSPITAL   (France)

Author keywords

Chronic bone infection; Continuous intravenous infusion; Vancomycin

Indexed keywords

CREATININE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BONE INFECTION; CLINICAL ARTICLE; COXITIS; CREATININE BLOOD LEVEL; DEBRIDEMENT; DERMATOMYCOSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG TISSUE LEVEL; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; FEMALE; FEMUR; GRAM POSITIVE BACTERIUM; HIP PROSTHESIS; HUMAN; HUMAN TISSUE; IMPLANT; INFECTIOUS ARTHRITIS; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; PATELLA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PRURITUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS BOVIS; TIBIA; TINNITUS; VERTEBRA; WOUND INFECTION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECALIS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS BOVIS;

EID: 0030841521     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00280.x     Document Type: Article

References (15)

1. Gentry LO. Antibiotic therapy for osteomyelitis. In Norden CW, ed. Infectious disease clinics of North America - osteomyelitis. Philadelphia: WB Saunders Company, 1990: 485-99.
2. Dirschl DR, Almekinders LC. Osteomyelitis - common causes and treatment recommendations. Drugs 1993; 45: 29-43.
3. Mader JT, Calhoun J. Osteomyelitis. In Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone Inc., 1995: 1039-51.
4. Mader JT, Landon GC, Calhoun J. Antimicrobial treatment of osteomyelitis. Clin Orthop Relat Res 1993; 295: 87-95.
5. Dellamonica P, Bernard E, Etesse H, Garraffo R, Drugeon HB. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. Eur J Clin Microbiol Infect Dis 1989; 8: 1024-30.
6. Rivière JP, Darbas H, Boyer G. Activité in vitro des glycopeptides sur 114 staphylocoques à coagulase négative: problèmes du test en diffusion pour la teicoplanine, paramètres 'd'alerte' incitant au contrôle de la CMI. Path Biol 1993; 41: 531-6.
7. Mainardi JL, Shlaes DM, Goering RV, Shlaes JH, Acar JF, Goldstein FW. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis 1995; 171: 1646-50.
8. Brinquin L, Rousseau JM, Boulesteix G, Diraison Y, Bonsignour JP. Vancomycine en perfusion continue dans les méningites à staphylocoques post-neurochirurgicales de l'adulte. Presse Méd 1993; 22: 1815-17.
9. Weinberg WG. Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial. Arch Intern Med 1985; 145: 1073-8.
10. Greenberg RN. Treatment of bone, joint and vascularaccess-associated Gram-positive bacterial infections with teicoplanin. Antimicrob Agents Chemother 1990; 34: 2392-7.
11. Norden CW, Shaffer M. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with vancomycin and rifampin. J Infect Dis 1983; 147: 352-7.
12. Mader JT, Adams K. Comparative evaluation of daptomycin (LY 146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus ostemyelitis in rabbits. Antimicrob Agents Chemother 1989; 33: 689-92.
13. Sheftel TG, Mader JT, Pennick JJ, Cierny G. Methicillin-resistant Staphylococcus aureus osteomyelitis. Clin Orthop Relat Res 1985; 198: 231-9.
14. Fitzpatrick DJ, Cafferkey MT, Toner M, Beattie T, Keane CT. Osteomyelitis with methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986; 8: 24-30.
15. Desplaces N, Mamoudy P, Larrouturou P, Rebischung JL, Kitzis MD. Vancomycine en perfusion continue (VPC) dans le traitement des infections ostéo-articulaires chroniques (OAC) à Staphylocoques multirésistants (SMR) [abstract 56/P5]. In: Programme et abstracts de la 14ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse, Paris, 1994: 111.